Preferential cerebral hypothermia. Tromethamine and dextran 40 and tolerance to circulatory arrest of 90 to 120 minutes.
D000136:Acid-Base Equilibrium; D000818:Animals; D001794:Blood Pressure; D001921:Brain; D002118:Calcium / Q000627:therapeutic use; D002339:Carotid Arteries; D002496:Central Venous Pressure; D002712:Chlorides / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use*; D005260:Female; D006324:Heart Arrest, Induced; D006339:Heart Rate; D007036:Hypothermia, Induced; D007263:Infusions, Parenteral; D007511:Ischemia / Q000150:complications; D007773:Lactates / Q000097:blood; D008297:Male; D009997:Osmotic Pressure; D010215:Papio; D010477:Perfusion; D011188:Potassium / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D012965:Sodium Chloride / Q000627:therapeutic use; D013118:Spinal Cord Diseases / Q000209:etiology; D014325:Tromethamine / Q000627:therapeutic use*
D002712:Chlorides; D003911:Dextrans; D007773:Lactates; D014325:Tromethamine; D012965:Sodium Chloride; D012964:Sodium; D011188:Potassium; D002118:Calcium